Takeda Pharmaceutical Li... (TKPHF)
OTC: TKPHF
· Real-Time Price · USD
29.45
0.00 (0.00%)
At close: Aug 13, 2025, 11:10 AM
29.45
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT
Takeda Pharmaceutical Cash Flow Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 137.12B | 108.14B | 208.22B | 290.14B | 150.07B | 144.17B | 178.33B | 191.72B | 301.42B | 317.04B | 274.53B | 213.2B | 197.46B | 230.17B | 438.69B | 473.3B | 431.38B | 376.17B | 180.59B | 97.6B | 147.44B |
Depreciation & Amortization | 750.81B | 761.4B | 758.37B | 758.48B | 748.72B | 728B | 702.67B | 692.49B | 677.62B | 664.4B | 655.26B | 625.67B | 598.49B | 583.15B | 570.27B | 562.74B | 561.03B | 559.67B | 566.01B | 522.21B | 548.9B |
Stock-Based Compensation | 74.01B | 72.87B | 73.43B | 73.83B | 70.81B | 70.87B | 67.53B | 65.31B | 63.82B | 60.67B | 57.5B | 52.09B | 47.48B | 43.73B | 43.37B | 42.3B | 37.93B | 39.43B | 36.92B | 34.59B | 35.78B |
Other Working Capital | -11.78B | -37.77B | -16.59B | -271.46B | -203.16B | -105.78B | -88.81B | 175.92B | 130.5B | 63.57B | 189.26B | 210.47B | 220.39B | 169.61B | 221.99B | 113.07B | 163.52B | 254.88B | 48.22B | 50.99B | 16.77B |
Other Non-Cash Items | 101.25B | 216.99B | 404.81B | 386.93B | 460.6B | 365.89B | -14.99B | -34.03B | -123.03B | -97.74B | 63.49B | 82.42B | 88.78B | 95.4B | -128.67B | -216.91B | -190.26B | -228.42B | -19.17B | -21.77B | -46.61B |
Deferred Income Tax | 51.99B | 66.94B | 26.61B | -20.45B | -95.73B | -91.41B | -30.1B | 2.4B | 53.23B | 58.05B | -1.4B | 24.97B | 37.6B | 72.41B | 48.81B | 51.8B | 27.54B | -9.94B | -61.99B | -5.24B | -52.72B |
Change in Working Capital | -12.88B | -169.16B | -72.97B | -327.75B | -255.35B | -216.32B | -171.99B | 45.34B | 12.26B | -25.26B | 10.03B | 30.33B | 71.04B | 98.61B | 177.79B | 107.47B | 166.07B | 275.78B | 93.94B | 94.18B | 62.92B |
Operating Cash Flow | 1,102.3B | 1,057.2B | 1,107.5B | 870.19B | 788.13B | 710.23B | 731.45B | 963.23B | 985.32B | 977.16B | 1,059B | 1,028.3B | 1,040.5B | 1,123.1B | 1,148.5B | 1,018.9B | 1,031.9B | 1,010.9B | 795.41B | 720.68B | 694.82B |
Capital Expenditures | -316.89B | -379.63B | -351.23B | -371.7B | -349.29B | -480.73B | -860.48B | -833.98B | -804.55B | -633.69B | -241.43B | -239.24B | -242.12B | -186.04B | -246.17B | -241.36B | -238.28B | -236.47B | -187.39B | -222.16B | -215.21B |
Cash Acquisitions | 103.59B | 74.3B | -7.05B | -34.56B | -39.96B | -39.59B | -17.93B | -6.7B | -14.68B | -70.66B | -52.56B | -59.66B | -62.31B | -32.11B | 347.25B | 462.94B | 504.98B | 513.56B | 193.85B | 100.27B | 444.48B |
Purchase of Investments | -79.93B | -111.38B | -111.34B | -46.23B | -37.76B | -6.77B | -9.43B | -7.72B | -7.89B | -10.15B | -6.18B | -9.44B | -8.02B | -8.34B | -10.72B | -9.97B | -12.33B | -12.6B | -9.7B | -9.82B | -7.93B |
Sales Maturities Of Investments | 25.25B | 29.44B | 33.61B | 30.5B | 12.79B | 8.02B | 2.79B | 4.49B | 16.62B | 22.25B | 21.41B | 25.25B | 22.62B | 16.92B | 16.95B | 34.02B | 30.65B | 74.6B | 75.32B | 59.47B | 79.38B |
Other Investing Acitivies | -101.21B | -158.63B | -123.33B | -85.5B | -35.74B | 39.63B | 44.19B | 31.63B | 31.58B | 85.14B | 84.51B | 45.04B | 22.72B | -45.73B | -119.44B | -114.35B | -82.97B | -87.66B | -27.58B | -54.34B | -78.01B |
Investing Cash Flow | -243.56B | -367.06B | -424.44B | -384.15B | -369.6B | -479.44B | -840.87B | -812.29B | -778.92B | -607.1B | -194.25B | -216.7B | -222.39B | -198.13B | 120.84B | 261.96B | 322.42B | 393.53B | 136.44B | -10.07B | 334.38B |
Debt Repayment | -743.9B | -314.31B | -122.09B | 252.28B | 164.76B | -165.49B | -240.19B | -409.88B | -263.58B | -400.07B | -498.95B | -436.1B | -633.69B | -849.81B | -1,003.2B | -930.3B | -1,986.2B | -1,760.1B | -1,508.7B | -1,384.7B | -750.78B |
Common Stock Repurchased | -101.58B | -51.86B | -1.88B | -1.88B | -1.88B | -2.33B | -2.33B | -2.33B | -2.33B | -26.93B | -51.92B | -101.92B | -101.92B | -77.53B | -52.54B | -2.55B | -2.55B | -2.14B | -2.15B | -2.15B | -5.87B |
Dividend Paid | -309.68B | -302.5B | -301.89B | -294.69B | -294.55B | -287.19B | -288.48B | -279.22B | -281.29B | -279.42B | -279.64B | -282.1B | -280.51B | -283.67B | -281.7B | -283.18B | -282.27B | -283.36B | -283B | -283.52B | -282.95B |
Other Financial Acitivies | -127.54B | -82.75B | -82B | 94.64B | 151.42B | 100.58B | 228.2B | 51.44B | -4.02B | -2.73B | -115.83B | 140.66B | 141.17B | 140.74B | 140.87B | -112.52B | 964.36B | 957.25B | 931.64B | 1,058.6B | 19.32B |
Financial Cash Flow | -1,282.7B | -751.42B | -486.17B | 72.04B | 41.43B | -332.73B | -302.79B | -639.99B | -551.21B | -709.15B | -946.35B | -679.45B | -874.94B | -1,070.3B | -1,196.5B | -1,328.5B | -1,306.6B | -1,088.4B | -862.21B | -611.75B | -1,020.3B |
Net Cash Flow | -455B | 179.18B | 205.03B | 540.22B | 487.89B | -328.34B | -396.78B | -480.09B | -329.61B | -316.17B | -39.2B | 190.26B | -8.93B | -116.53B | 106.71B | -22.99B | 65.13B | 328.61B | 49.36B | 87.35B | -3.96B |
Free Cash Flow | 785.41B | 666.63B | 745.34B | 487.56B | 427.91B | 229.5B | -129.03B | 129.24B | 180.76B | 343.47B | 817.62B | 789.09B | 798.37B | 937.07B | 902.31B | 777.57B | 793.64B | 774.46B | 608.01B | 498.51B | 479.62B |